GSEP
GSK icon

Golden State Equity Partners’s GSK GSK Stock Holding History

Golden State Equity Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.5K Sell
697
-3,161
-82% -$167K 0.1% 125
2026
Q1 		$213K Buy
+3,858
New +$209K 0.02% 629
2024
Q4 		– Sell
-160
Closed -$6.54K – 617
2024
Q3 		$6.54K Buy
+160
New +$6.54K ﹤0.01% 620

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Golden State Equity Partners's GSK Position: Q2 2026 in Review

Golden State Equity Partners reduced its GSK (GSK) stake by 82% in Q2 2026, selling an estimated $167K and leaving 697 shares worth $36.5K. The position accounts for 0.1% of the portfolio, ranked #125.

Golden State Equity Partners first reported a position in GSK in Q3 2024 and has held it in 3 quarters since. The position peaked at $213K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Golden State Equity Partners held 697 shares of GSK worth $36.5K as of Q2 2026.
  • Golden State Equity Partners sold 3,161 GSK shares in Q2 2026, an estimated $167K.
  • GSK made up 0.1% of Golden State Equity Partners's portfolio in Q2 2026, its #125 holding.
  • Golden State Equity Partners first reported a position in GSK in Q3 2024 and has held it in 3 quarters since.
  • Golden State Equity Partners's GSK position peaked at $213K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.